홈 › 방광암 › 캘리포니아 › Los Angeles
CA Los Angeles의 방광암 임상 시험
방광암 관련 연구 24개가 Los Angeles 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
피험자 모집 중2상
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
피험자 모집 중1상
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
피험자 모집 중2상
- USC Norris Comprehensive Cancer Center ( Site 0123), Los Angeles
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
피험자 모집 중2상
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
피험자 모집 중1상
- Ronald Reagan UCLA Medical Center, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
피험자 모집 중2상
- Keck Medicine of USC Koreatown, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
피험자 모집 중1/2상
- START Los Angeles, LLC, Los Angeles
- Los Angeles Cancer Network - Century City, Los Angeles
- (IRB# 26-0433) Ronald Reagan UCLA Medical Center, Drug Information Center, Los Angeles
- 외 1개
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
피험자 모집 중3상
- TRIO-US (Translational Research in Oncology-US), Los Angeles
- UCLA Hematology/Oncology - Santa Monica, Los Angeles
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
피험자 모집 중1상
- USC/Norris Comprehensive Cancer Center, Los Angeles
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
피험자 모집 중2/3상
- Research Site, Los Angeles
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
피험자 모집 중1상
- University of California, Los Angeles (UCLA) - Division of Hematology-Oncology, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
피험자 모집 중1상
- The Angeles Clinic and Research Institute, Los Angeles
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
피험자 모집 중1/2상
- USC/Norris Comprehensive Cancer Center, Los Angeles
- Tower Urology, Los Angeles
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
피험자 모집 중2상
- UCLA Downtown Los Angeles Primary & Specialty Care, Los Angeles
- Kaiser Permanente Los Angeles Medical Offices, Los Angeles
- Kaiser Permanente West Los Angeles Medical Center, Los Angeles
- 외 6개
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
피험자 모집 중1상
- USC Norris Comprehensive Cancer Center, Los Angeles
Predicting BCG Response
피험자 모집 중관찰 연구
- Cedars-Sinai Medical Center, Los Angeles
- UCLA, Los Angeles
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
피험자 모집 중1상
- Ronald Reagan UCLA Medical Center, Los Angeles
- The Regents of the University of California, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
피험자 모집 중
- Urology Group of Southern California, Los Angeles
- Comprehensive Urology, Los Angeles
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
피험자 모집 중1상
- USC - Norris Comprehensive Cancer Center, Los Angeles
A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer
피험자 모집 중관찰 연구
- Cedars-Sinai Medical Center, Los Angeles
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
피험자 모집 중관찰 연구
- Cedars-Sinai Medical Center, Los Angeles
- UCLA Medical Center, Los Angeles
Blue Light Cystoscopy With Cysview® Registry
피험자 모집 중관찰 연구
- USC/Norris Comprehensive Cancer Center, Los Angeles
- University of California Los Angeles, Los Angeles
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
피험자 모집 중
- Cedars-Sinai Medical Center (CSMC), Los Angeles
- University of California Los Angeles, Los Angeles
Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study
피험자 모집 중
- UCLA, Los Angeles
다른 도시의 방광암 시험
- New York City, NY연구 35개
- Houston, TX연구 31개
- Nashville, TN연구 31개
- Dallas, TX연구 27개
- Washington, DC연구 26개
- Boston, MA연구 26개
- Baltimore, MD연구 24개
- St. Louis, MO연구 22개
- Seattle, WA연구 21개
- Edison, NJ연구 21개
- Philadelphia, PA연구 21개
- Chicago, IL연구 21개
Los Angeles의 다른 연구
- 비소세포폐암연구 87개
- 암 (전체)연구 74개
- 유방암연구 73개
- 전립선암연구 61개
- 대장직장암연구 59개
- 전이성 암연구 57개
- 난소암연구 50개
- 폐암연구 45개
- 두경부 편평세포암연구 42개
- 췌장암연구 35개
- 자궁내막암연구 34개
- 흑색종연구 34개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.